INVENTIVA ADS/1 O.N. revenue breakdown overview

INVENTIVA ADS/1 O.N. revenue for the last year amounted to 17.10 M EUR, the most of which — 17.12 M EUR — came from its highest performing source at the moment, Oral Small Molecule Therapies, the year earlier bringing 11.96 M EUR. The greatest contribution to the revenue figure was made by Japan — last year it brought INVENTIVA ADS/1 O.N. 12.49 M EUR.